Literature DB >> 1930181

Changes in expression of angiotensin receptor subtypes in the rat aorta during development.

M Viswanathan1, K Tsutsumi, F M Correa, J M Saavedra.   

Abstract

Quantitative autoradiography was used to characterize angiotensin AT1 and AT2 receptors, in the rat aorta at three developmental ages; embryonic day 18 (E18), and postnatal weeks 2 and 8. The expression of angiotensin receptors was higher in the aorta of E18 and 2-week-old rat. A major proportion of the angiotensin receptors expressed in the aorta at these two ages was AT2 (84 and 81% respectively). Conversely, in the aorta of 8-week-old rats, AT1 was the predominant angiotensin receptor subtype (71%). In 8-week-old rats, the AT2 subtype was also present (28%). In pre- and postnatal rats, [125I]Sar1-angiotensin II binding to AT1 receptors was sensitive to GTP gamma S whereas binding to AT2 receptors was not. AT2 receptors may serve an important role during stages of rapid growth of the aorta, and also have a significant function in the adult vasculature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930181     DOI: 10.1016/0006-291x(91)91723-p

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

2.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

Authors:  M Nakajima; H G Hutchinson; M Fujinaga; W Hayashida; R Morishita; L Zhang; M Horiuchi; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

4.  Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta.

Authors:  M Viswanathan; C Strömberg; A Seltzer; J M Saavedra
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture.

Authors:  H Matsubara; M Kanasaki; S Murasawa; Y Tsukaguchi; Y Nio; M Inada
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.

Authors:  Xiao C Li; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

7.  Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.

Authors:  Y A Lee; C S Liang; M A Lee; K Lindpaintner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.

Authors:  M Akishita; M Ito; J Y Lehtonen; L Daviet; V J Dzau; M Horiuchi
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.

Authors:  E J Freeman; E A Tallant
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Angiotensin type 2-receptor (AT2R) activation induces hypotension in apolipoprotein E-deficient mice by activating peroxisome proliferator-activated receptor-γ.

Authors:  Ming Li; Thor Tejada; Jonathan P Lambert; Chad K Nicholson; Eiji Yahiro; Vats T Ambai; Syeda F Ali; Eddie W Bradley; Robert M Graham; Louis J Dell'Italia; John W Calvert; Nawazish Naqvi
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.